Dhansa Labs Limited (NSE:DHANSA)

India · Delayed Price · Currency is INR

20.10

-0.40 (-1.95%)

At close: Aug 14, 2026

-50.12% (1Y)

Market Cap	501.43M -50.1%
Revenue (ttm)	1.39B +4.9%
Net Income	49.38M +7.1%
EPS	1.96 +5.9%
Shares Out	24.95M
PE Ratio	10.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,000
Open	21.50
Previous Close	20.50
Day's Range	20.10 - 21.50
52-Week Range	16.20 - 47.00
Beta	1.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Dhansa Labs

Dhansa Labs Limited manufactures and distributes agro chemicals and home hygiene products in India. The company offers 2,4-D acid tech, sodium salt, amine salt, ethyl hexyl ester tech, and ethyl ester tech; and chlorpyriphos, thiamethoxam, pretilachlor, metribuzin, hexaconazole, clodinofob tech, and lambda cyhalothrine tech. It also exports its products. The company was formerly known as Ambey Laboratories Limited and changed its name to Dhansa Labs Limited in March 2026. Dhansa Labs Limited was incorporated in 1985 and is based in Gurugram, In... [Read more]

Industry Agricultural Chemicals

Founded 1985

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol DHANSA

Full Company Profile

Financial Performance

In fiscal year 2026, Dhansa Labs's revenue was 1.43 billion, an increase of 7.48% compared to the previous year's 1.33 billion. Earnings were 55.23 million, an increase of 15.47%.

Financial Statements